Outcomes of Acute Exacerbation of Severe Congestive Heart FailureQuality of Life, Resource Use, and Survival
Open Access
- 25 May 1998
- journal article
- research article
- Published by American Medical Association (AMA) in Archives of internal medicine (1960)
- Vol. 158 (10) , 1081-1089
- https://doi.org/10.1001/archinte.158.10.1081
Abstract
CONGESTIVE HEART failure (CHF) is a common disease in the United States, with a prevalence of 7.4 per 1000 men and 4.7 per 1000 women (age-adjusted to the US 1991 population).1 In aggregate, there are an estimated 1 to 2 million adults with CHF at any time in this country,2 and the prevalence is on the rise.3 Hospitalization rates for CHF also have been increasing.3 Despite the high cost of health care for patients with CHF, survival rates are poor. Knowledge of the health-related quality of life (HRQL) outcomes of severe CHF may guide decision making and be useful in assessment of new therapies for this population.This publication has 5 references indexed in Scilit:
- Quality of Life After Cardiopulmonary ResuscitationChest, 1994
- Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failureThe Lancet, 1993
- Effect of Enalapril on Mortality and the Development of Heart Failure in Asymptomatic Patients with Reduced Left Ventricular Ejection FractionsNew England Journal of Medicine, 1992
- Effect of Enalapril on Survival in Patients with Reduced Left Ventricular Ejection Fractions and Congestive Heart FailureNew England Journal of Medicine, 1991
- Effects of Enalapril on Mortality in Severe Congestive Heart FailureNew England Journal of Medicine, 1987